tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 129 are a BUY (59.45%), 71 are a HOLD (32.72%), 17 are a SELL (7.83%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 65.13% that have a potential upside of 17.75% achieved within 158 days.
Matthew Taylor’s has documented 419 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BDX, Becton Dickinson and Company at 10-Feb-2026.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$142
$32.44 (29.61%)
$169
1 months 10 days ago
(02-Feb-2026)
18/27 (66.67%)
$32.59 (29.79%)
511
Buy Since 06-Jun-2019
$140
$30.44 (27.78%)
$160
1 months 17 days ago
(23-Jan-2026)
12/16 (75%)
$32.58 (30.33%)
485
Buy Since 19-Sep-2024
$135
$25.44 (23.22%)
$150
1 months 17 days ago
(23-Jan-2026)
2/5 (40%)
$27.58 (25.67%)
143
Buy Since 27-Jun-2018
$125
$15.44 (14.09%)
$154
1 months 17 days ago
(23-Jan-2026)
3/6 (50%)
$17.58 (16.37%)
595
Buy Since 18-Jul-2018
$138
$28.44 (25.96%)
$142
1 months 17 days ago
(23-Jan-2026)
9/15 (60%)
$30.58 (28.47%)
310
Which stock is Matthew Taylor is most bullish on?
Which stock is Matthew Taylor is most reserved on?
What Year was the first public recommendation made by Matthew Taylor?
